AB Sciex Buys Labindia's Mass Spec Business | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – AB Sciex has acquired Labindia's mass spectrometry business for an undisclosed sum in a deal that the two firms said represents AB Sciex's deepening investment into India's scientific community.

AB Sciex said today that the purchase of the Delhi-based services provider is the result of a successful ongoing partnership between the companies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.